Griffith experiment
Generated by GPT-5-miniExpansion Funnel Raw 53 → Dedup 2 → NER 2 → Enqueued 0
| Griffith experiment | |
|---|---|
| Name | Griffith experiment |
| Researcher | Frederick Griffith |
| Year | 1928 |
| Field | Microbiology |
| Organism | Streptococcus pneumoniae |
| Country | United Kingdom |
| Published in | British Medical Journal |
Griffith experiment The Griffith experiment was a 1928 bacterial study by Frederick Griffith that provided early evidence for the transfer of hereditary information between cells. Conducted with strains of Streptococcus pneumoniae in Kensington (London) laboratory settings, the work influenced later discoveries by scientists at institutions such as the Rockefeller Institute and the University of Oxford. Griffith's results set the stage for molecular genetics research by groups including those led by Oswald Avery, Alfred Hershey, and Martha Chase.
Background
By the 1920s, bacteriology laboratories in London, Paris, and Berlin investigated virulence and immunity in pathogens like Streptococcus pneumoniae, which had been implicated in outbreaks observed during the First World War and postwar public health studies. Frederick Griffith, a researcher associated with the London School of Hygiene & Tropical Medicine, worked amid contemporary research into bacterial serotypes, capsule formation, and pneumococcal pathogenesis that involved investigators from the Wellcome Trust and clinical units at St Thomas' Hospital. Prevailing hypotheses about heredity were dominated by work from figures linked to the Rosalind Franklin era later replaced by molecular models; in Griffith's time, heredity was studied in organisms ranging from bacteria to model animals in laboratories such as Cold Spring Harbor Laboratory and universities including Cambridge and Edinburgh.
The bacterial strains used by Griffith were distinguished by colony morphology and virulence: a smooth, polysaccharide-capsulated virulent strain and a rough, noncapsulated avirulent strain. These phenotypes had been characterized in comparative studies by researchers at institutions like the Ludwig Maximilian University of Munich and the Pasteur Institute.
Experimental procedure
Griffith worked with mice as an animal model, sourcing virulent and avirulent pneumococcal strains characterized by serotyping methods developed in collaboration with bacteriologists from Guy's Hospital and contemporaries across European medical schools. He injected mice with live virulent (smooth) bacteria, live avirulent (rough) bacteria, heat-killed virulent bacteria, and mixtures combining heat-killed virulent with live avirulent bacteria. The heat inactivation step mirrored sterilization practices used in clinical bacteriology overseen by laboratories at the Hôpital Pitié-Salpêtrière and the Johns Hopkins Hospital.
Throughout the procedure, Griffith documented survival outcomes, performed bacteriological cultures on tissues recovered from mice, and carried out colony morphology assessments using microscopy techniques comparable to those applied in research at the Salk Institute decades later. He observed and compared colony types grown on agar media similar to formulations in use at the Royal Society of Medicine and international labs in Vienna and Milan.
Results and observations
Griffith found that mice injected with live virulent (smooth) bacteria developed fatal pneumonia, consistent with reports from clinical series at St Bartholomew's Hospital. Mice given live avirulent (rough) organisms survived, and mice injected with heat-killed virulent bacteria also survived, paralleling sterilization control findings from bacteriology centers in Berlin.
Critically, mice injected with a mixture of heat-killed virulent bacteria and live avirulent bacteria succumbed to infection. Cultures recovered from these mice yielded live virulent (smooth) bacteria, a result corroborated by colony morphology and pathogenicity testing similar to assays used at the Mayo Clinic and in research at the Karolinska Institute. Griffith reported that something transferable from the dead virulent bacteria converted the live avirulent bacteria into a virulent form; he termed this phenomenon "transformation." The observation linked to contemporaneous clinical microbiology documented by laboratories such as Mount Sinai Hospital.
Interpretation and significance
Griffith cautiously interpreted his results as evidence that a "transforming principle" from dead virulent cells could genetically alter live avirulent cells, an idea that challenged strictly reductionist and nontransferable models of hereditary material current in some medical schools of the era, including debates at the Royal Institution. Although Griffith did not identify the chemical nature of the transforming principle, his experiment became a pivotal conceptual bridge between classical bacteriology and molecular genetics.
The study inspired subsequent, focused biochemical analyses by teams at the Rockefeller Institute and led directly to experiments by Oswald Avery, Colin MacLeod, and Maclyn McCarty that identified DNA as the transforming agent, connecting Griffith's findings to breakthroughs in labs like the Carnegie Institution and influencing later viral genetics work by Alfred Hershey and Martha Chase. The logic of transformation underpinned advances at institutions engaged in gene theory debates, including Harvard University and the University of Cambridge.
Subsequent developments and legacy
Following Griffith, Avery, MacLeod, and McCarty published biochemical evidence implicating DNA in transformation, prompting debates among geneticists at meetings of the Royal Society and scientific bodies across Europe and North America. The conceptual lineage from Griffith's experiment extended into the DNA structure discovery by James Watson and Francis Crick at the Cavendish Laboratory and influenced molecular biology programs at the Massachusetts Institute of Technology, the University of California, Berkeley, and other research centers.
Griffith's transformation phenomenon also became a methodological foundation for genetic engineering, recombinant DNA technologies developed at institutions such as Stanford University and Genentech, and for bacterial genetics approaches in laboratories like EMBL and the Max Planck Institute. The experiment is frequently cited in historical surveys produced by the Wellcome Collection and in retrospectives at the National Institutes of Health. Its legacy persists in modern microbiology, infectious disease research, and in educational curricula from medical schools such as King's College London to university departments worldwide.